» Articles » PMID: 7103547

Long-term Outcome of Primary Nephrotic Syndrome

Overview
Journal Arch Dis Child
Specialty Pediatrics
Date 1982 Jul 1
PMID 7103547
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

One hundred and fourteen children with primary nephrotic syndrome were followed up prospectively for periods of between 5 and 14 years. Urine samples from 94 of them became protein-free during the initial 8-week course of prednisone, and the outcome for these children was good: 74 of them have been free of symptoms for at least 3 years, 18 have had relapses during the last 3 years, and only one child still has proteinuria. All these children have normal renal function and blood pressure. One child died accidentally. Twenty children did not respond to the initial prednisone treatment. Thirteen of them had remissions later, of whom 2 have had relapses during the last 3 years. Seven were totally resistant to prednisone 4 of whom died in renal failure, the remaining 3 have persistent proteinuria with normal levels of creatinine; one has high blood pressure too. Remission during the initial treatment indicated a good prognosis, but two-thirds of the initial non-responders also fared well.

Citing Articles

Single (375 mg/m) vs. double dose of rituximab along with mycophenolate mofetil for children with steroid-dependent/frequently relapsing nephrotic syndrome: a multicentre open-label randomized controlled trial.

Sinha R, Pradhan S, Raut S, Banerjee S, Sarkar S, Akhtar S Pediatr Nephrol. 2024; 40(4):995-1004.

PMID: 39729126 DOI: 10.1007/s00467-024-06619-8.


Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children.

Larkins N, Hahn D, Liu I, Willis N, Craig J, Hodson E Cochrane Database Syst Rev. 2024; 11:CD002290.

PMID: 39513526 PMC: 11544715. DOI: 10.1002/14651858.CD002290.pub6.


Corticosteroid therapy for nephrotic syndrome in children.

Hahn D, Samuel S, Willis N, Craig J, Hodson E Cochrane Database Syst Rev. 2024; 8:CD001533.

PMID: 39171624 PMC: 11339925. DOI: 10.1002/14651858.CD001533.pub7.


Genetic risk variants for childhood nephrotic syndrome and corticosteroid response.

Cason R, Chambers E, Tu T, Chryst-Stangl M, Huggins K, Lane B Front Pediatr. 2023; 11:1248733.

PMID: 37868272 PMC: 10588181. DOI: 10.3389/fped.2023.1248733.


Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin nephropathy by promoting autophagy and inhibiting apoptosis.

Ji B, Liu J, Yin Y, Xu H, Shen Q, Yu J Cell Death Dis. 2023; 14(9):601.

PMID: 37689694 PMC: 10492865. DOI: 10.1038/s41419-023-06124-0.


References
1.
Churg J, Habib R, White R . Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. Lancet. 1970; 760(1):1299-302. DOI: 10.1016/s0140-6736(70)91905-7. View

2.
Siegel N, Goldberg B, Krassner L, HAYSLETT J . Long-term follow-up of children with steroid-responsive nephrotic syndrome. J Pediatr. 1972; 81(2):251-8. DOI: 10.1016/s0022-3476(72)80291-9. View

3.
Habib R, Kleinknecht C . The primary nephrotic syndrome of childhood. Classification and clinicopathologic study of 406 cases. Pathol Annu. 1971; 6:417-74. View

4.
Schwartz M, Schwartz G, Cornfeld D . A 16-year follow-up study of 163 children with nephrotic syndrome. Pediatrics. 1974; 54(5):547-52. View